Advertisement
Screener

Spero Therapeutics, Inc. (SPRO) Stockholders' Equity Attributable to Noncontrolling Interest

2.8 / 5 stars · 68/120 Roast Me

Spero Therapeutics, Inc. Stockholders' Equity Attributable to Noncontrolling Interest

Spero Therapeutics, Inc. (SPRO) had Stockholders' Equity Attributable to Noncontrolling Interest of $355.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-04.

Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest

us-gaap:MinorityInterest · last filed 2020-03-16

  • 2019-09-30: Stockholders' Equity Attributable to Noncontrolling Interest $355.00K.
  • 2019-06-30: Stockholders' Equity Attributable to Noncontrolling Interest $355.00K.
  • 2019-03-31: Stockholders' Equity Attributable to Noncontrolling Interest $355.00K.
  • 2018-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $355.00K.
Period endStockholders' Equity Attributable to Noncontrolling Interest
2019-09-30$355.00K
10-Q · filed 2019-11-04
2019-06-30$355.00K
10-Q · filed 2019-08-08
2019-03-31$355.00K
10-Q · filed 2019-05-09
2018-12-31$355.00K
10-K · filed 2020-03-16
2018-09-30$355.00K
10-Q · filed 2018-11-08
2018-06-30$355.00K
10-Q · filed 2018-08-09
2018-03-31$355.00K
10-Q · filed 2018-05-10
2017-12-31$355.00K
10-K · filed 2019-03-14
2017-09-30$361.00K
10-Q · filed 2017-12-14
2016-12-31-$3.81M
10-K · filed 2018-04-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cingulate Inc. (CING)United States$0.073B-2.64
Lunai Bioworks Inc. (LNAI)United States$0.072B-0.11
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
Yarrow Bioscience, Inc. (YARW)United States$0.070B
OS Therapies Inc (OSTX)United States$0.076B-2.17
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17